<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00534339</url>
  </required_header>
  <id_info>
    <org_study_id>10042</org_study_id>
    <nct_id>NCT00534339</nct_id>
  </id_info>
  <brief_title>EasyBand GOAL Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <brief_summary>
    <textblock>
      Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable&#xD;
      gastric banding device for the treatment of morbidly obese patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    This study was withdrawn to further optimize the device. No patients were enrolled in the&#xD;
    trial.&#xD;
  </why_stopped>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent excess weight loss (%EWL)</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Morbid Obesity</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Easyband (Telemetrically adjustable gastric banding device)</intervention_name>
    <description>EasyBand</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Minimum 3 year history of morbid obesity with documented failure of conservative,&#xD;
             non-surgical means of weight reduction within 1 year prior to the screening visit;&#xD;
&#xD;
          -  BMI &gt;/= 40 kg/m2, or BMI &gt;/= 35 kg/m2 and &lt;/= 40 kg/m2 with one or more significant&#xD;
             medical conditions related to obesity;&#xD;
&#xD;
          -  Candidate for surgical weight loss intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous surgical treatment of obesity;&#xD;
&#xD;
          -  Patient already implanted with a device sensitive to radiofrequency emissions&#xD;
             (implantable pacemaker, implantable defibrillator, etc);&#xD;
&#xD;
          -  Physical or emotional conditions that may prohibit surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allergan Medical</last_name>
    <role>Study Director</role>
    <affiliation>Allergan Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>USA</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Canada</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <study_first_submitted>September 21, 2007</study_first_submitted>
  <study_first_submitted_qc>September 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2007</study_first_posted>
  <last_update_submitted>October 3, 2014</last_update_submitted>
  <last_update_submitted_qc>October 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2014</last_update_posted>
  <responsible_party>
    <name_title>Allergan Medical</name_title>
    <organization>Allergan</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

